Ignite Creation Date:
2025-12-24 @ 10:53 PM
Ignite Modification Date:
2026-02-21 @ 11:35 PM
Study NCT ID:
NCT01532869
Status:
COMPLETED
Last Update Posted:
2016-09-23
First Post:
2012-02-10
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of RoActemra/Actemra (Tocilizumab) Versus Placebo in Patients With Systemic Sclerosis
Sponsor:
Hoffmann-La Roche
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-03
Start Date Type:
None
Primary Completion Date:
2014-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-08
Completion Date Type:
ACTUAL
First Submit Date:
2012-02-10
First Submit QC Date:
None
Study First Post Date:
2012-02-15
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2015-10-08
Results First Submit QC Date:
None
Results First Post Date:
2015-11-05
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-08-02
Last Update Post Date:
2016-09-23
Last Update Post Date Type:
ESTIMATED